|
Positive Results for Reslizumab in Asthma Trials
Monthly Prescribing Reference Teva announced positive results from its Phase 3 studies of reslizumab in patients with uncontrolled moderate to severe asthma with elevated eosinophils, treated with standard of care therapies. Reslizumab is an investigational humanized monoclonal … Teva's Asthma Drug 'Significantly' Improves Lung Function In Phase 3 Trials |
View full post on asthma – Google News